The Belfast, Northern Ireland-based pharmaceutical engineering company Sepha has been acquired by global inspection and test organisation TASI Group. The acquisition by TASI, which has headquarters in Cincinnati, US, marks the next phase in the international development of Sepha by providing resources to expand Sepha’s customer base and to fund R&D into new products. Sepha customers, which include most of the world’s top 50 pharmaceutical companies, will also benefit from TASI’s worldwide network of sales and engineering staff.
TASI is a leading manufacturer of leak test and measurement equipment used to improve quality and manufacturing efficiency in the automotive, energy, plastics, industrial, medical device and pharmaceutical markets. As part of the TASI Group, Sepha will be able to increase sales in important markets such North America, China and India.
Commenting on the acquisition during a recent visit to Sepha, TASI President & CEO David Huberfield said: “We are very pleased to partner with Sepha in expanding our global life sciences markets and products. We have an expansive engineering, manufacturing and service presence on three continents and sales coverage in almost 100 countries. Sepha joins Bonfiglioli Engineering, Air Logic Power Systems [ALPS], Cincinnati Test Systems and ATC Automation, all leaders in their fields, in providing a complementary range of integrated test systems, pack inspection and instrumentation to pharmaceutical and medical device customers.”
Sepha CEO John Haran added: “Sales of our pack inspection and deblistering machines have increased rapidly in recent years. Pharma companies are now very focused on the issues caused by poor packaging, namely increased costs and lower quality. We will be accelerating product development to maintain Sepha’s lead in the inspection sector in response to market demand.”
Sepha Ltd, +44 2890 484848, info@sepha.com, www.sepha.com / www.tasigroup.com